DataMEDS AI, Inc.

MEDS

NASDAQHealthcareMedical - Distribution

在 GoAI 中打开

前收盘价

US$1.37

−US$0.08 · -5.52%

8月21日 16:00 ET

盘前

US$1.3571

−US$0.0129 · -0.94%

8月24日 7:29 ET

盘中时间采用ET。市场数据可能有所延迟。

公司概况

公司网站

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.

行业: Medical - Distribution
部门: Healthcare
总部: US
首席执行官: Prashant Patel
上市以来: 2025年2月21日
雇员: 31

市场位置

日内区间

当前US$1.37，

US$1.36US$1.51

52周区间

当前US$1.37，

US$1.255US$97.50

开盘价: US$1.43
前收盘价: US$1.45
成交量: 6.96万; 0.13× 平均值
平均成交量: 54.08万; 日均成交量
市值: 359.43万 USD
贝塔: -1.52; 市场参考 1
50天平均值: US$2.7622; 低于平均水平-50.40%
200天平均值: US$11.673; 低于平均水平-88.26%

财务数据

财务快照

估值与收益率

企业价值: 5309.14万 USD
市盈率（TTM）: -0.03×
市净率（TTM）: -0.18×
市销率（TTM）: 0.45×
EV/EBITDA: -0.57×
盈利收益率: -357.03%
自由现金流收益率: -38.27%
股息率: 0.00%

盈利能力和效率

毛利率: -129.55%
营业利润率: -719.27%
净利润率: -1100.30%
净资产收益率: 813.59%
资产收益率: -332.49%
投入资本回报率: -659.05%

财务健康

负债权益比: -1.67×
流动比率: 0.09×

MEDS 消息

accessnewswire.com2026年8月17日

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Revenues grew 14% reaching $1.779M in Q2/26, beating management projections Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from ‘WGRX' to ‘MEDS' on…

阅读源码

accessnewswire.com2026年8月14日

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial…

阅读源码

accessnewswire.com2026年8月12日

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

GLP-1 agonist drugs now available Integration of online store CorexaRx.com into Health Lives Here app now complete Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available Revenue stabilized…

阅读源码

accessnewswire.com2026年8月10日

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and…

阅读源码

accessnewswire.com2026年8月6日

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date

TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and…

阅读源码

accessnewswire.com2026年8月5日

DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"

Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient engagement tools…

阅读源码